1
|
Krolewiecki A, Lifschitz A, Moragas M, Travacio M, Valentini R, Alonso DF, Solari R, Tinelli MA, Cimino RO, Álvarez L, Fleitas PE, Ceballos L, Golemba M, Fernández F, de Oliveira DF, Astudillo G, Baeck I, Farina J, Cardama GA, Mangano A, Spitzer E, Gold S, Lanusse C. Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959]". EClinicalMedicine 2021; 39:101119. [PMID: 34462733 PMCID: PMC8387727 DOI: 10.1016/j.eclinm.2021.101119] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Abstract
[This corrects the article DOI: 10.1016/j.eclinm.2021.100959.].
Collapse
Affiliation(s)
- Alejandro Krolewiecki
- Instituto de Investigaciones de Enfermedades Tropicales (IIET-CONICET), Sede Regional Orán, Universidad Nacional de Salta, Argentina
- Corresponding author at: Instituto de Investigaciones de Enfermedades Tropicales. UNSa. Alvarado 751 (4530), Orán, Argentina.
| | - Adrián Lifschitz
- Laboratorio de Farmacología, Centro de Investigación Veterinaria de Tandil (CIVETAN), CONICET-CICPBA-UNCPBA, Facultad de Ciencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos Aires, Tandil, Argentina
| | - Matías Moragas
- Unidad de Virología y Epidemiología Molecular, Hospital de Pediatría "Prof. Dr. Juan P. Garrahan"-CONICET, Ciudad de Buenos Aires, Argentina
| | - Marina Travacio
- Cátedra de Química General e Inorgánica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina
| | - Ricardo Valentini
- Departamento de Medicina. Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina
| | - Daniel F. Alonso
- Centro de Oncología Molecular y Traslacional (COMTra) y Plataforma de Servicios Biotecnológicos, Departamento de Ciencia y Tecnología, Universidad Nacional de Quilmes, Buenos Aires, Argentina
| | - Rubén Solari
- Hospital Francisco J. Muñiz, Buenos Aires, Argentina
| | | | - Rubén O. Cimino
- Instituto de Investigaciones de Enfermedades Tropicales (IIET-CONICET), Sede Regional Orán, Universidad Nacional de Salta, Argentina
| | - Luis Álvarez
- Laboratorio de Farmacología, Centro de Investigación Veterinaria de Tandil (CIVETAN), CONICET-CICPBA-UNCPBA, Facultad de Ciencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos Aires, Tandil, Argentina
| | - Pedro E. Fleitas
- Instituto de Investigaciones de Enfermedades Tropicales (IIET-CONICET), Sede Regional Orán, Universidad Nacional de Salta, Argentina
| | - Laura Ceballos
- Laboratorio de Farmacología, Centro de Investigación Veterinaria de Tandil (CIVETAN), CONICET-CICPBA-UNCPBA, Facultad de Ciencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos Aires, Tandil, Argentina
| | - Marcelo Golemba
- Unidad de Virología y Epidemiología Molecular, Hospital de Pediatría "Prof. Dr. Juan P. Garrahan"-CONICET, Ciudad de Buenos Aires, Argentina
| | - Florencia Fernández
- Unidad de Virología y Epidemiología Molecular, Hospital de Pediatría "Prof. Dr. Juan P. Garrahan"-CONICET, Ciudad de Buenos Aires, Argentina
| | - Diego Fernández de Oliveira
- Departamento de Medicina. Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina
| | | | - Inés Baeck
- Departamento de Medicina. Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina
| | - Javier Farina
- Servicio de Infectología. Hospital Cuenca Alta, Cañuelas, Argentina
| | - Georgina A. Cardama
- Centro de Oncología Molecular y Traslacional (COMTra) y Plataforma de Servicios Biotecnológicos, Departamento de Ciencia y Tecnología, Universidad Nacional de Quilmes, Buenos Aires, Argentina
| | - Andrea Mangano
- Unidad de Virología y Epidemiología Molecular, Hospital de Pediatría "Prof. Dr. Juan P. Garrahan"-CONICET, Ciudad de Buenos Aires, Argentina
| | | | - Silvia Gold
- Fundación Mundo Sano, Buenos Aires, Argentina
| | - Carlos Lanusse
- Laboratorio de Farmacología, Centro de Investigación Veterinaria de Tandil (CIVETAN), CONICET-CICPBA-UNCPBA, Facultad de Ciencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos Aires, Tandil, Argentina
| |
Collapse
|
2
|
Krolewiecki A, Lifschitz A, Moragas M, Travacio M, Valentini R, Alonso DF, Solari R, Tinelli MA, Cimino RO, Álvarez L, Fleitas PE, Ceballos L, Golemba M, Fernández F, Fernández de Oliveira D, Astudillo G, Baeck I, Farina J, Cardama GA, Mangano A, Spitzer E, Gold S, Lanusse C. Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial. EClinicalMedicine 2021; 37:100959. [PMID: 34189446 PMCID: PMC8225706 DOI: 10.1016/j.eclinm.2021.100959] [Citation(s) in RCA: 59] [Impact Index Per Article: 19.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/08/2023] Open
Abstract
BACKGROUND There are limited antiviral options for the treatment of patients with COVID-19. Ivermectin (IVM), a macrocyclic lactone with a wide anti-parasitary spectrum, has shown potent activity against SARS-CoV-2 in vitro. This study aimed at assessing the antiviral effect of IVM on viral load of respiratory secretions and its relationship with drug concentrations in plasma. METHODS Proof-of-concept, pilot, randomized, controlled, outcome-assessor blinded trial to evaluate antiviral activity of high-dose IVM in 45 COVID-19 hospitalized patients randomized in a 2:1 ratio to standard of care plus oral IVM at 0·6 mg/kg/day for 5 days versus standard of care in 4 hospitals in Argentina. Eligible patients were adults with RT-PCR confirmed SARS-CoV-2 infection within 5 days of symptoms onset. The primary endpoint was the difference in viral load in respiratory secretions between baseline and day-5, by quantitative RT-PCR. Concentrations of IVM in plasma were measured. Study registered at ClinicalTrials.gov: NCT04381884. FINDINGS 45 participants were recruited (30 to IVM and 15 controls) between May 18 and September 9, 2020. There was no difference in viral load reduction between groups but a significant difference was found in patients with higher median plasma IVM levels (72% IQR 59-77) versus untreated controls (42% IQR 31-73) (p = 0·004). Mean ivermectin plasma concentration levels correlated with viral decay rate (r: 0·47, p = 0·02). Adverse events were similar between groups. No differences in clinical evolution at day-7 and day-30 between groups were observed. INTERPRETATION A concentration dependent antiviral activity of oral high-dose IVM was identified at a dosing regimen that was well tolerated. Large trials with clinical endpoints are necessary to determine the clinical utility of IVM in COVID-19. FUNDING This work was supported by grant IP-COVID-19-625, Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación, Argentina and Laboratorio ELEA/Phoenix, Argentina.
Collapse
Affiliation(s)
- Alejandro Krolewiecki
- Instituto de Investigaciones de Enfermedades Tropicales (IIET-CONICET), Sede Regional Orán, Universidad Nacional de Salta, Alvarado 751 (4530), Orán, Argentina
- Corresponding author.
| | - Adrián Lifschitz
- Laboratorio de Farmacología, CONICET-CICPBA-UNCPBA, Facultad de Ciencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos Aires, Centro de Investigación Veterinaria de Tandil (CIVETAN), Tandil, Argentina
| | - Matías Moragas
- Unidad de Virología y Epidemiología Molecular, Hospital de Pediatría "Prof. Dr. Juan P. Garrahan"-CONICET, Ciudad de Buenos Aires, Argentina
| | - Marina Travacio
- Cátedra de Química General e Inorgánica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina
| | - Ricardo Valentini
- Departamento de Medicina, Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina
| | - Daniel F. Alonso
- Centro de Oncología Molecular y Traslacional (COMTra) y Plataforma de Servicios Biotecnológicos, Departamento de Ciencia y Tecnología, Universidad Nacional de Quilmes, Buenos Aires, Argentina
| | - Rubén Solari
- Hospital Francisco J. Muñiz, Buenos Aires, Argentina
| | | | - Rubén O. Cimino
- Instituto de Investigaciones de Enfermedades Tropicales (IIET-CONICET), Sede Regional Orán, Universidad Nacional de Salta, Alvarado 751 (4530), Orán, Argentina
| | - Luis Álvarez
- Laboratorio de Farmacología, CONICET-CICPBA-UNCPBA, Facultad de Ciencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos Aires, Centro de Investigación Veterinaria de Tandil (CIVETAN), Tandil, Argentina
| | - Pedro E. Fleitas
- Instituto de Investigaciones de Enfermedades Tropicales (IIET-CONICET), Sede Regional Orán, Universidad Nacional de Salta, Alvarado 751 (4530), Orán, Argentina
| | - Laura Ceballos
- Laboratorio de Farmacología, CONICET-CICPBA-UNCPBA, Facultad de Ciencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos Aires, Centro de Investigación Veterinaria de Tandil (CIVETAN), Tandil, Argentina
| | - Marcelo Golemba
- Unidad de Virología y Epidemiología Molecular, Hospital de Pediatría "Prof. Dr. Juan P. Garrahan"-CONICET, Ciudad de Buenos Aires, Argentina
| | - Florencia Fernández
- Unidad de Virología y Epidemiología Molecular, Hospital de Pediatría "Prof. Dr. Juan P. Garrahan"-CONICET, Ciudad de Buenos Aires, Argentina
| | - Diego Fernández de Oliveira
- Departamento de Medicina, Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina
| | | | - Inés Baeck
- Departamento de Medicina, Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina
| | - Javier Farina
- Servicio de Infectología, Hospital Cuenca Alta, Cañuelas, Argentina
| | - Georgina A. Cardama
- Centro de Oncología Molecular y Traslacional (COMTra) y Plataforma de Servicios Biotecnológicos, Departamento de Ciencia y Tecnología, Universidad Nacional de Quilmes, Buenos Aires, Argentina
| | - Andrea Mangano
- Unidad de Virología y Epidemiología Molecular, Hospital de Pediatría "Prof. Dr. Juan P. Garrahan"-CONICET, Ciudad de Buenos Aires, Argentina
| | | | - Silvia Gold
- Fundación Mundo Sano, Buenos Aires, Argentina
| | - Carlos Lanusse
- Laboratorio de Farmacología, CONICET-CICPBA-UNCPBA, Facultad de Ciencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos Aires, Centro de Investigación Veterinaria de Tandil (CIVETAN), Tandil, Argentina
| |
Collapse
|
3
|
Garay OU, Guiñazú G, Cornistein W, Farina J, Valentini R, Levy Hara G. Budget impact analysis of using procalcitonin to optimize antimicrobial treatment for patients with suspected sepsis in the intensive care unit and hospitalized lower respiratory tract infections in Argentina. PLoS One 2021; 16:e0250711. [PMID: 33930050 PMCID: PMC8087000 DOI: 10.1371/journal.pone.0250711] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2020] [Accepted: 04/13/2021] [Indexed: 11/18/2022] Open
Abstract
BACKGROUND Inappropriate antibiotic use represents a major global threat. Sepsis and bacterial lower respiratory tract infections (LRTIs) have been linked to antimicrobial resistance, carrying important consequences for patients and health systems. Procalcitonin-guided algorithms may represent helpful tools to reduce antibiotic overuse but the financial burden is unclear. The aim of this study was to estimate the healthcare and budget impact in Argentina of using procalcitonin-guided algorithms to guide antibiotic prescription. METHODS A decision tree was used to model health and cost outcomes for the Argentinean health system, over a one-year duration. Patients with suspected sepsis in the intensive care unit and hospitalized patients with LRTI were included. Model parameters were obtained from a focused, non-systematic, local and international bibliographic search, and validated by a panel of local experts. Deterministic and probabilistic sensitivity analyses were performed to analyze the uncertainty of parameters. RESULTS The model predicted that using procalcitonin-guided algorithms would result in 734.5 [95% confidence interval (CI): 1,105.2;438.8] thousand fewer antibiotic treatment days, 7.9 [95% CI: 18.5;8.5] thousand antibiotic-resistant cases avoided, and 5.1 [95% CI: 6.7;4.2] thousand fewer Clostridioides difficile cases. In total, this would save $422.4 US dollars (USD) [95% CI: $935;$267] per patient per year, meaning cost savings of $83.0 [95% CI: $183.6;$57.7] million USD for the entire health system and $0.4 [95% CI: $0.9;$0.3] million USD for a healthcare provider with 1,000 cases per year of sepsis and LRTI patients. The sensitivity analysis showed that the probability of cost-saving for the sepsis patient group was lower than for the LRTI patient group (85% vs. 100%). CONCLUSIONS Healthcare and financial benefits can be obtained by implementing procalcitonin-guided algorithms in Argentina. Although we found results to be robust on an aggregate level, some caution must be used when focusing only on sepsis patients in the intensive care unit.
Collapse
Affiliation(s)
- Osvaldo Ulises Garay
- Market Access and Medical Affairs, Roche Diagnostics, Buenos Aires, Argentina
- * E-mail:
| | - Gonzalo Guiñazú
- Ricardo Gutiérrez Children’s Hospital, Buenos Aires, Argentina
| | | | - Javier Farina
- Hospital Cuenca Alta Néstor Kirchner, Buenos Aires, Argentina
| | | | - Gabriel Levy Hara
- Unit of Infectious Diseases, Hospital Carlos G Durand, Buenos Aires, Argentina
| |
Collapse
|
4
|
de Landa GF, Porrini MP, Revainera P, Porrini DP, Farina J, Correa-Benítez A, Maggi MD, Eguaras MJ, Quintana S. Pathogens Detection in the Small Hive Beetle (Aethina tumida (Coleoptera: Nitidulidae)). Neotrop Entomol 2021; 50:312-316. [PMID: 32845459 DOI: 10.1007/s13744-020-00812-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/08/2019] [Accepted: 08/10/2020] [Indexed: 06/11/2023]
Abstract
Aethina tumida Murray is currently a worldwide emergent pest of Apis mellifera L. hives. Although the damaging effect on the colony stores and brood is well known, the possible role of these beetles as a disease carrier is not clear. This is the first report of DNA presence of the trypanosome honeybee parasite Lotmaria passim and Crithidia bombi, and the Apis mellifera filamentous virus (AmFV) in A. tumida. Further studies will be needed to determine if A. tumida is indeed a mechanical or biological vector of these pathogens.
Collapse
Affiliation(s)
- G Fernandez de Landa
- Centro de Investigación en Abejas Sociales (CIAS), Instituto de Investigaciones en Producción Sanidad y Ambiente (IIPROSAM-CONICET-CIC), Facultad de Ciencias Exactas y Naturales, Univ Nacional de Mar del Plata, Buenos Aires, Argentina.
| | - M P Porrini
- Centro de Investigación en Abejas Sociales (CIAS), Instituto de Investigaciones en Producción Sanidad y Ambiente (IIPROSAM-CONICET-CIC), Facultad de Ciencias Exactas y Naturales, Univ Nacional de Mar del Plata, Buenos Aires, Argentina
| | - P Revainera
- Centro de Investigación en Abejas Sociales (CIAS), Instituto de Investigaciones en Producción Sanidad y Ambiente (IIPROSAM-CONICET-CIC), Facultad de Ciencias Exactas y Naturales, Univ Nacional de Mar del Plata, Buenos Aires, Argentina
| | - D P Porrini
- GENEBSO, INBIOTEC, UNMdP, CONICET, Mar del Plata, Argentina
| | - J Farina
- Museo Municipal de Ciencias Naturales de Mar del Plata (Lorenzo Scaglia), Buenos Aires, Argentina
| | - A Correa-Benítez
- Depto de Medicina y Zootecnia de Abejas, Conejos y Organismos Acuáticos (DMZA:CyOA), Facultad de Medicina Veterinaria y Zootecnia (FMVZ), Univ Nacional Autónoma de Mexico (UNAM), Ciudad de Mexico, Mexico
| | - M D Maggi
- Centro de Investigación en Abejas Sociales (CIAS), Instituto de Investigaciones en Producción Sanidad y Ambiente (IIPROSAM-CONICET-CIC), Facultad de Ciencias Exactas y Naturales, Univ Nacional de Mar del Plata, Buenos Aires, Argentina
| | - M J Eguaras
- Centro de Investigación en Abejas Sociales (CIAS), Instituto de Investigaciones en Producción Sanidad y Ambiente (IIPROSAM-CONICET-CIC), Facultad de Ciencias Exactas y Naturales, Univ Nacional de Mar del Plata, Buenos Aires, Argentina
| | - S Quintana
- Centro de Investigación en Abejas Sociales (CIAS), Instituto de Investigaciones en Producción Sanidad y Ambiente (IIPROSAM-CONICET-CIC), Facultad de Ciencias Exactas y Naturales, Univ Nacional de Mar del Plata, Buenos Aires, Argentina
| |
Collapse
|
5
|
Lopardo G, Belloso WH, Nannini E, Colonna M, Sanguineti S, Zylberman V, Muñoz L, Dobarro M, Lebersztein G, Farina J, Vidiella G, Bertetti A, Crudo F, Alzogaray MF, Barcelona L, Teijeiro R, Lambert S, Scublinsky D, Iacono M, Stanek V, Solari R, Cruz P, Casas MM, Abusamra L, Luciardi HL, Cremona A, Caruso D, de Miguel B, Lloret SP, Millán S, Kilstein Y, Pereiro A, Sued O, Cahn P, Spatz L, Goldbaum F. RBD-specific polyclonal F(ab´) 2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial. EClinicalMedicine 2021; 34:100843. [PMID: 33870149 PMCID: PMC8037439 DOI: 10.1016/j.eclinm.2021.100843] [Citation(s) in RCA: 26] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/20/2021] [Revised: 03/10/2021] [Accepted: 03/17/2021] [Indexed: 12/15/2022] Open
Abstract
BACKGROUND passive immunotherapy is a therapeutic alternative for patients with COVID-19. Equine polyclonal antibodies (EpAbs) could represent a source of scalable neutralizing antibodies against SARS-CoV-2. METHODS we conducted a double-blind, randomized, placebo-controlled trial to assess efficacy and safety of EpAbs (INM005) in hospitalized adult patients with moderate and severe COVID-19 pneumonia in 19 hospitals of Argentina. Primary endpoint was improvement in at least two categories in WHO ordinal clinical scale at day 28 or hospital discharge (ClinicalTrials.gov number NCT04494984). FINDINGS between August 1st and October 26th, 2020, a total of 245 patients were enrolled. Enrolled patients were assigned to receive two blinded doses of INM005 (n = 118) or placebo (n = 123). Median age was 54 years old, 65•1% were male and 61% had moderate disease at baseline. Median time from symptoms onset to study treatment was 6 days (interquartile range 5 to 8). No statistically significant difference was noted between study groups on primary endpoint (risk difference [95% IC]: 5•28% [-3•95; 14•50]; p = 0•15). Rate of improvement in at least two categories was statistically significantly higher for INM005 at days 14 and 21 of follow-up. Time to improvement in two ordinal categories or hospital discharge was 14•2 (± 0•7) days in the INM005 group and 16•3 (± 0•7) days in the placebo group, hazard ratio 1•31 (95% CI 1•0 to 1•74). Subgroup analyses showed a beneficial effect of INM005 over severe patients and in those with negative baseline antibodies. Overall mortality was 6•9% the INM005 group and 11•4% in the placebo group (risk difference [95% IC]: 0•57 [0•24 to 1•37]). Adverse events of special interest were mild or moderate; no anaphylaxis was reported. INTERPRETATION Albeit not having reached the primary endpoint, we found clinical improvement of hospitalized patients with SARS-CoV-2 pneumonia, particularly those with severe disease.
Collapse
Affiliation(s)
- Gustavo Lopardo
- Hospital Municipal Dr. Bernardo Houssay, Pte Hipólito Yrigoyen 1757, Florida, Provincia de Buenos Aires, Argentina
- Fundación del Centro de Estudios Infectológicos (FUNCEI), French 3085, Ciudad Autónoma de Buenos Aires, Buenos Aires C1425, Argentina
| | - Waldo H. Belloso
- Department of Research, Hospital Italiano de Buenos Aires. Pres. Tte. Gral. Juan Domingo Perón 4190, Ciudad Autónoma de Buenos Aires, Buenos Aires C1199, Argentina
| | - Esteban Nannini
- Departamento de Enfermedades Infecciosas, Sanatorio Británico, Paraguay 40, Rosario, Santa Fé S2000 CVB, Argentina
- Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina
| | - Mariana Colonna
- Inmunova S.A., 25 de mayo 1021, Villa Lynch, Gral. San Martín, Buenos Aires CP B1650HMP, Argentina
| | - Santiago Sanguineti
- Inmunova S.A., 25 de mayo 1021, Villa Lynch, Gral. San Martín, Buenos Aires CP B1650HMP, Argentina
| | - Vanesa Zylberman
- Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina
- Inmunova S.A., 25 de mayo 1021, Villa Lynch, Gral. San Martín, Buenos Aires CP B1650HMP, Argentina
| | - Luciana Muñoz
- Inmunova S.A., 25 de mayo 1021, Villa Lynch, Gral. San Martín, Buenos Aires CP B1650HMP, Argentina
| | - Martín Dobarro
- Sanatorio Sagrado Corazón (OSECAC), Bartolomé Mitre 1955, Ciudad Autónoma de Buenos Aires, Buenos Aires CP1039, Argentina
| | - Gabriel Lebersztein
- Sanatorio Sagrado Corazón (OSECAC), Bartolomé Mitre 1955, Ciudad Autónoma de Buenos Aires, Buenos Aires CP1039, Argentina
| | - Javier Farina
- Hospital de Alta Complejidad Cuenca Alta S.A.M.I.C. Dr. Néstor Carlos Kirchner, RP6, Cañuelas, Provincia de Buenos Aires, Argentina
| | - Gabriela Vidiella
- Sanatorio Agote. Dr. Luis Agote 2477, Ciudad Autónoma de Buenos Aires, Buenos Aires C1425 EOE, Argentina
| | - Anselmo Bertetti
- Sanatorio Güemes, Francisco Acuña de Figueroa 1240, Ciudad Autónoma de Buenos Aires, Buenos Aires C1180, Argentina
| | - Favio Crudo
- Hospital Municipal Emilio Zerboni, Moreno 90, San Antonio de Areco, Provincia de Buenos Aires B2760, Argentina
- Universidad Nacional de San Antonio de Areco, Av. Güiraldes 689, San Antonio de Areco, Provincia de Buenos Aires, Argentina
| | | | - Laura Barcelona
- Hospital Municipal Dr. Bernardo Houssay, Pte Hipólito Yrigoyen 1757, Florida, Provincia de Buenos Aires, Argentina
| | - Ricardo Teijeiro
- Hospital General de Agudos Dr. Ignacio Pirovano, Av. Monroe 3555, Ciudad Autónoma de Buenos Aires, Buenos Aires C1428, Argentina
| | - Sandra Lambert
- Hospital de Alta Complejidad El Cruce Néstor Kirchner, Av. Calchaquí 5401, Florencio Varela, Provincia de Buenos Aires, Argentina
| | - Darío Scublinsky
- Clínica Zabala. Av. Cabildo 1295, Ciudad Autónoma de Buenos Aires, Buenos Aires C1426 AAM, Argentina
| | - Marisa Iacono
- Hospital Provincial Neuquén Dr. Castro Rendón, Buenos Aires 450, Neuquén Q8300, Argentina
| | - Vanina Stanek
- Sección de Infectología, Servicio de Medicina Interna, Hospital Italiano de Buenos Aires. Pres. Tte. Gral. Juan Domingo Perón 4190, Ciudad Autónoma de Buenos Aires, Buenos Aires C1199, Argentina
| | - Rubén Solari
- Hospital de Infecciosas Francisco Javier Muñiz, Uspallata 2272, Ciudad Autónoma de Buenos Aires, Buenos Aires C1282, Argentina
| | - Pablo Cruz
- Centro Gallego de Buenos Aires, Av. Belgrano 2199, Ciudad Autónoma de Buenos Aires, Buenos Aires C1096, Argentina
| | - Marcelo Martín Casas
- Clínica Adventista Belgrano. Estomba 1710, Ciudad Autónoma de Buenos Aires, Buenos Aires C1430 EGF, Argentina
| | - Lorena Abusamra
- Hospital Municipal Dr. Diego Thompson, Avellaneda 33, Villa Lynch, Gral. San Martín, Buenos Aires B1650, Argentina
| | - Héctor Lucas Luciardi
- Hospital Centro de Salud Zenón J. Santillán, Av. Avellaneda 750, San Miguel de Tucumán, Tucumán T4000, Argentina
| | - Alberto Cremona
- Hospital Italiano La Plata, Av. 51, La Plata, Provincia de Buenos Aires B1900, Argentina
| | - Diego Caruso
- Hospital Español, Av. Belgrano 2975, Ciudad Autónoma de Buenos Aires, Buenos Aires C1209, Argentina
| | | | - Santiago Perez Lloret
- Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina
- Departamento de Docencia e Investigación, Facultad de Ciencias Médicas, Universidad Católica Argentina, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina
- Universidad Abierta Interamericana, Centro de Altos Estudios en Ciencias Humanas y de la Salud (UAI-CAECIHS), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Av. San Juan 951, Ciudad Autónoma de Buenos Aires, Buenos Aires C1147 AAH, Argentina
| | - Susana Millán
- mAbxience, Manuel Pombo Angulo 28, 3rd floor, Madrid 28050, Spain
| | - Yael Kilstein
- PHV LATAM, AES, Amenábar 3851, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
| | - Ana Pereiro
- Fundación Mundo Sano, Paraguay 1535, Ciudad Autónoma de Buenos Aires, Buenos Aires C1061ABC, Argentina
| | - Omar Sued
- Fundación Huésped, Pasaje Ángel Peluffo 3932PB, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
| | - Pedro Cahn
- Fundación Huésped, Pasaje Ángel Peluffo 3932PB, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
| | - Linus Spatz
- Inmunova S.A., 25 de mayo 1021, Villa Lynch, Gral. San Martín, Buenos Aires CP B1650HMP, Argentina
| | - Fernando Goldbaum
- Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina
- Inmunova S.A., 25 de mayo 1021, Villa Lynch, Gral. San Martín, Buenos Aires CP B1650HMP, Argentina
- Fundación Instituto Leloir, IIBBA-CONICET. Av. Patricias Argentinas 435, Buenos Aires C1405BWE, Argentina
- CRIP - Centro de Rediseño e Ingeniería de Proteínas UNSAM Campus Miguelete. 25 de Mayo y Francia Villa Lynch, Gral. San Martín, Buenos Aires B1650HMK, Argentina
- Corresponding author at: Inmunova S.A., 25 de mayo 1021, Villa Lynch, Gral. San Martín, Buenos Aires CP B1650HMP, Argentina.
| | | |
Collapse
|
6
|
Zubeldia Brenner LA, Díaz NA, Esposto S, Bordo NS, Farina J. [Herpes zoster complicated by necrotizing bacterial infection in a patient with HIV / Aids]. Medicina (B Aires) 2021; 81:485. [PMID: 34137718] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/12/2023] Open
Affiliation(s)
- Liucó A Zubeldia Brenner
- Servicio de Infectología, Sector Microbiología, Hospital de Alta Complejidad Cuenca Alta Néstor Kirchner Cañuelas, Buenos Aires, Argentina. E-mail:
| | - Natalia A Díaz
- Servicio de Infectología, Sector Microbiología, Hospital de Alta Complejidad Cuenca Alta Néstor Kirchner Cañuelas, Buenos Aires, Argentina
| | - Sofía Esposto
- Servicio de Infectología, Sector Microbiología, Hospital de Alta Complejidad Cuenca Alta Néstor Kirchner Cañuelas, Buenos Aires, Argentina
| | - Natalia S Bordo
- Servicio de Laboratorio, Sector Microbiología, Hospital de Alta Complejidad Cuenca Alta Néstor Kirchner Cañuelas, Buenos Aires, Argentina
| | - Javier Farina
- Servicio de Infectología, Sector Microbiología, Hospital de Alta Complejidad Cuenca Alta Néstor Kirchner Cañuelas, Buenos Aires, Argentina
| |
Collapse
|
7
|
Díaz NA, Farina J, Herrera J, Ezcurra MC. [Candidemia: characteristics in elderly patients]. Rev Chilena Infectol 2020; 37:288-294. [PMID: 32853321 DOI: 10.4067/s0716-10182020000300288] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2019] [Accepted: 04/14/2020] [Indexed: 11/17/2022] Open
Abstract
BACKGROUND Candidemia is a nosocomial bloodstream infection and an important cause of comorbidity and mortality. Elderly patients present the highest rates of candidemia but data about this population is scarce. AIMS To describe characteristics of candidemia in elderly patients, to identify risk factors associated with mortality and to evaluate the usefulness of a predictive score. METHODS A retrospective observational study of candidemia in elderly patients from a tertiary care hospital was carried out. We analyzed all Candida bloodstream infections during an eight-year period in patients older than 60 years. RESULTS Fifty-nine episodes were included. Diabetes was the most frequent comorbidity. Most candidemia were catheter related infections (45%). Only 17% of patients had a Candida score > 2.5. Overall mortality at 48 hours was 20%, and at 15 days was 49%. Mortality-related factors were shock, assisted mechanical ventilation, thrombocytopenia, renal failure and leukocytosis (p range < 0.0001-0.006). On multivariate analysis septic shock was independently associated with mortality (HR 4.02 [CI 95% 1.18-13.72] p = 0.026). CONCLUSIONS Nearly half of patients with candidemia died during the first fifteen days. Shock, assisted mechanical ventilation, thrombocytopenia, renal failure, and leukocytosis were factors associated with mortality. The predictive score was not useful in this population.
Collapse
Affiliation(s)
- Natalia A Díaz
- Servicio de Infectología, Hospital Cesar Milstein, Buenos Aires, Argentina
| | - Javier Farina
- Servicio de Infectología, Hospital Cesar Milstein, Buenos Aires, Argentina
| | - Jorge Herrera
- Servicio de Microbiología, Hospital Cesar Milstein, Buenos Aires, Argentina
| | - M Cristina Ezcurra
- Servicio de Infectología, Hospital Cesar Milstein, Buenos Aires, Argentina
| |
Collapse
|
8
|
Nemirovsky C, López Furst MJ, Pryluka D, De Vedia L, Scapellato P, Colque A, Barcelona L, Desse J, Caradonti M, Varcasia D, Ipohorski G, Votta R, Zylberman M, Romani A, Valdez P, Amalfa F, Lucero C, Fernández Lausi A, Fernández Garces A, Rodríguez C, Chattas A, Farina J, Clara L, Nuccetelli Y. [Argentine Intersociety Consensus on Urinary Infection 2018-2019 - Part II]. Medicina (B Aires) 2020; 80:241-247. [PMID: 32442938] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/11/2023] Open
Abstract
The second part of the Inter-Society Argentine Consensus on Urinary Tract Infection (UTI) includes the analysis of special situations. In patients with urinary catheter, urine culture should be requested only in the presence of UTI symptomatology, before instrumentation of the urinary tract, or as a post-transplant control. The antibiotics recommended for empirical treatment in patients without risk factors are third-generation cephalosporins or aminoglycosides. UTIs associated with stones are always considered complicated. In case of obstruction with urosepsis, an emergency drainage should be performed via a percutaneous nefrostomy or ureteral stenting. In patients with stents or ureteral prostheses, such as double J catheters, empirical treatment should be based on epidemiology, prior antibiotics, and clinical status. Before the extracorporeal lithotripsy procedure, bacteriuria should be investigated and antibiotic prophylaxis should be administered in case of positive result, according to the antibiogram. First generation cephalosporins or aminoglycosides are valid alternatives. The use of antibiotic prophylaxis with first-generation cephalosporins or aminoglycosides before percutaneous nephrolithotomy is recommended. Transrectal prostatic biopsy can be associated with infectious complications, such as UTI or acute prostatitis, mainly due to Escherichia coli or other enterobacteria. In patients without risk factors for multiresistant bacteria and negative urine culture, prophylaxis with intravenous amikacin or ceftriaxone is recommended. In patients with positive urine culture, prophylaxis will be performed according to the antibiogram, from 24 hours before to 24 hours post-procedure. For the targeted treatment of post-transrectal biopsy prostatitis, carbapenems for 3-4 weeks are the treatment of choice.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | - Roberto Votta
- Federación Argentina de Sociedades de Ginecología y Obstetricia, Argentina
| | | | | | | | - Flavia Amalfa
- Sociedad Argentina de Bacteriología, Micología y Parasitología Clínica, Argentina
| | - Celeste Lucero
- Administración Nacional de Laboratorios e Institutos de Salud Dr. Carlos Malbrán, Buenos Aires, Argentina
| | | | | | | | - Ana Chattas
- Sociedad Argentina de Infectología, Argentina
| | | | | | | |
Collapse
|
9
|
Farina J, Cornistein W, Balasini C, Chuluyan J, Blanco M. [Central venous catheter related infections. Inter-Societies update and recommendations]. Medicina (B Aires) 2019; 79:53-60. [PMID: 30694189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/09/2023] Open
Abstract
Representatives of the Argentine Society of Infectious Diseases (SADI) and the Argentine Society of Intensive Therapy (SATI) joined together to issue specific recommendations for the diagnosis, treatment, and prevention of intravascular catheter related infections (CRI). The methodology used was the analysis of the literature published in the last 10 years, complemented with the opinion of experts and local data. This document aims to promote effective measures to reduce the risk of CRI and to offer basic tools for diagnosis optimization based on clinical and microbiological criteria, orientation on empirical and targeted antibiotic schemes, posology, and administration of antibiotics in critical patients. It also offers a diagnostic and treatment algorithm for use in the care activity, as well as considerations on the dosage of antibiotics. The joint work of both societies highlights the concern for the management of CRI and the importance of ensuring improvement in daily practices. Through this recommendation, local guidelines are established to optimize the diagnosis, treatment and prevention of CRI in order to reduce morbidity and mortality, days of hospitalization, costs, and antimicrobial resistance.
Collapse
Affiliation(s)
- Javier Farina
- Hospital Mariano y Luciano de la Vega, Moreno, Provincia de Buenos Aires, Argentina. E-mail:
| | - Wanda Cornistein
- Hospital Universitario Austral, Provincia de Buenos Aires, Argentina
| | - Carina Balasini
- Hospital Interzonal General de Agudos José de San Martín, La Plata, Provincia de Buenos Aires, Argentina
| | - Juan Chuluyan
- Hospital General de Agudos Dr. Teodoro álvarez, Buenos Aires, Argentina
| | - Miriam Blanco
- Hospital de Alta Complejidad en Red El Cruce, Florencio Varela, Provincia de Buenos Aires, Argentina
| |
Collapse
|
10
|
Ruiz M, Mesplet F, Alonso J, Diaz N, Di Masi SA, Cox W, Arriola S, Rebora J, Farina J, Terusi A, Cusmano L, Viteri A, Zugasti N, Shimank E, Ezcurra M. Infection control program in elderly adults center. Int J Infect Dis 2018. [DOI: 10.1016/j.ijid.2018.04.3485] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
11
|
Torres JA, Mesplet F, Arriola S, Ruiz M, Andino S, Cox W, Diaz N, Herrera J, Liliana C, Farina J, Rebora J, Terusi A, Viteri A, Ezcurra M. Osteoarticular Implant Infections by Candida spp., experience at an elderly adults’ center. Int J Infect Dis 2018. [DOI: 10.1016/j.ijid.2018.04.3938] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
12
|
Arriola S, Ruiz M, Cox W, Masi SAD, Diaz N, Alonso J, Mesplet F, Zugasti N, Cusmano L, Farina J, Rebora J, Terusi A, Viteri A, Ezcurra M. Analysis of postoperative spinal surgery infections at an elderly care center. Int J Infect Dis 2018. [DOI: 10.1016/j.ijid.2018.04.4309] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
13
|
Cornistein W, Staneloni M, Rodríguez V, Farina J, Mora C, Fabbro L, Robles D, Salazar E, Freuler C, Del Castillo M. Impact of discontinuing contact precautions against vancomycin resistant Enterococcus: Multicenter study in Argentina. Int J Infect Dis 2018. [DOI: 10.1016/j.ijid.2018.04.4003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
14
|
De Gregorio S, Araujo K, Farina J, Avagnina M, Real J, Foccoli M. Gastrointestinal Infection by Cytomegalovirus in Immunocompetent Patient: Casuistry 10 Years. Open Forum Infect Dis 2016. [DOI: 10.1093/ofid/ofw172.520] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Stella De Gregorio
- Hospital de Clinicas “Jose de San Martin”, Ciudad de Buenos Aires, Argentina
| | - Karina Araujo
- Hospital de Clinicas “Jose de San Martin”, Ciudad de Buenos Aires, Argentina
| | - Javier Farina
- Hospital de Clinicas “Jose de San Martin”, Ciudad de Buenos Aires, Argentina
| | - Maria Avagnina
- Hospital de Clinicas “Jose de San Martin”, Ciudad de Buenos Aires, Argentina
| | - Jorgelina Real
- Hospital de Clinicas “Jose de San Martin”, Ciudad de Buenos Aires, Argentina
| | - Monica Foccoli
- Hospital de Clinicas “Jose de San Martin”, Ciudad de Buenos Aires, Argentina
| |
Collapse
|
15
|
Rossi A, Assunção O, Gonçalves N, Dantas R, Farina J. O6.3 Cross-cultural adaptation and validity of the Body Image Quality of Life Inventory (BIQLI) to be used with Brazilian burned patients. Burns 2011. [DOI: 10.1016/s0305-4179(11)70016-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
16
|
Rozenfeld M, Farina J, Rodrigues R, Maineri N, Alves R, Grossi J, Kaefer H, Bressel M. P3–079: Cognitive Impairment Not Dementia (CIND): Level of education is important for the results of Rivermead memory test. Alzheimers Dement 2006. [DOI: 10.1016/j.jalz.2006.05.1346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
17
|
Farina J. Peritoneal dialysis: a case for home visits. Nephrol Nurs J 2001; 28:423-8. [PMID: 12143464] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/25/2023]
Abstract
Peritoneal dialysis (PD) training usually takes place within the dialysis unit. Home visits, however, provide an ideal way for the dialysis team to assess and observe the implementation of the training objectives and to uphold the continuation of care between the dialysis unit and the home. This article describes the benefits and limitations of performing home visits as well as practical guidelines, including the use of an assessment record to document the home visit.
Collapse
Affiliation(s)
- J Farina
- Baxter Healthcare Corporation, McGaw Park, IL, USA
| |
Collapse
|
18
|
Abstract
The issues of confidentiality and boundaries cause ethical dilemmas for psychotherapists. We investigated whether therapists have ethical attitudes to confidentiality and boundaries that are unique to their professional group compared with lay persons and whether gender or professional characteristics are associated with these attitudes. Clinical vignettes capturing ethical dilemmas regarding confidentiality and boundaries were presented to 93 psychotherapists of different professional backgrounds (professional group) and 55 staff and students from the fields of law and the humanities (lay group). In general, the lay group showed a greater tendency to maintain confidentiality than the professional group. Regarding boundaries, the majority of psychotherapists were against initiating any sexual relationship with current patients, former patients, students, or supervisees; the differences between the groups in this area were statistically significant. The vast majority of therapists (96.7%) disapproved of accepting money in advance compared with only 54.4% of the lay group. Analysis of the psychotherapists by professional background revealed that for the majority of the vignettes, there was no difference in attitude to confidentiality and boundaries between psychiatrists, psychologists, and social workers. The present study shows that therapists have different ethical codes from nontherapists regarding the issues of boundaries and the treatment contract. Therapists are stricter than nontherapists regarding issues of boundaries but less strict regarding issues of confidentiality, and there are some minor differences in the attitudes to these issues among different types of therapists.
Collapse
Affiliation(s)
- S Fennig
- Shalvata Mental Health Center, Hod Hasharon, Israel
| | | | | | | | | | | | | |
Collapse
|
19
|
Menna-Barreto M, Rabolini G, Bianchini O, Jardim C, Doval A, Farina J, Lima C, Novoa P, Hall W. 5-04-03 Human T-lymphotropic virus type II (ETLV-II) associated myelopathy in urban areas of Brazil. J Neurol Sci 1997. [DOI: 10.1016/s0022-510x(97)86227-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
20
|
|
21
|
Wanke MM, Farina J, Loza MH, Rebuelto M, Concannon PW. Induction of estrus in bitches with normal and persistent anestrus using human menopausal gonadotropin (hMG). Theriogenology 1997; 47:935-42. [PMID: 16728043 DOI: 10.1016/s0093-691x(97)00049-6] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/1996] [Accepted: 11/07/1996] [Indexed: 11/26/2022]
Abstract
Human menopausal gonadotropin (hMG) was administered intramuscularly to 10 bitches during apparently normal anestrus (n = 7) or persistent anestrus (n = 3). Each dog received a 75-IU dose of hMG (75 IU LH and 75 IU FSH; 1 to 7 units/kg) daily for nine days. Nine bitches responded with obvious signs of proestrus within 3 to 9 days. Of these, 3 bitches exhibited a weak proestrus while 2 exhibited a normal estrus and ovulation but failed to become pregnant The remaining 4 bitches became pregnant at the induced cycle and produced normal litters at 72 to 85 d after the start of treatment, including 1 bitch that had been treated at 24 mo after the last estrus. In 2 cases, treatment resulted in ovulation following 25 or 34 mo of chronic pubertal anestrus, 1 of which became pregnant. The results suggest that hMG can be a useful gonadotropin preparation for inducing estrus in dogs.
Collapse
Affiliation(s)
- M M Wanke
- Section of Theriogenology, Faculty of Veterinary Sciences, University of Buenos Aires, Chorroarin 290, 1486 Buenos Aires (Cap. Fed.), Argentina
| | | | | | | | | |
Collapse
|
22
|
Abstract
Putrescine (PUT) and the putrescine analogues, 1,3-diaminopropane (DAP) and 1,6-diaminohexane (DAH), were administered to pregnant female mice during the time of maximal fetal ornithine decarboxylase (ODC) activity, days 10-14 of gestation. Such treatment resulted in an inhibition of fetal ODC activity, as measured 2 hours later, and a proportional decrease in fetal weight, as measured on day 18 of gestation. The order of effectiveness for these compounds was DAP greater than DAH greater than PUT. Neither DAP nor DAH nor PUT were fetocidal nor maternally lethal under the treatment regimen employed. The generality of the effect of these compounds, i.e., the retardation of fetal growth and the lack of gross malformations, is consistent with the hypothesis that they are interfering with a primary process, probably protein synthesis. The restricted time span of effectiveness implies that these compounds are specific inhibitors of ODC and that decreased ODC activity is producing an effect on growth.
Collapse
|
23
|
Farina J. Skilled anesthesia is often key figure during surgery. CANA 1980; 34:10-1. [PMID: 6903453] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|
24
|
|
25
|
Abstract
Two patients with Huntington's chorea were anaesthetized successfully with a technique including thiopentone, nitrous oxide and either a narcotic analgesic or halothane; pancuronium was employed for myoneural blockade.
Collapse
|
26
|
|
27
|
Stafford RH, Farina J, Otterson WN. Osteogenesis imperfecta diagnosed in utero in conjunction with Rh sensitization. South Med J 1974; 67:111-2. [PMID: 4855574 DOI: 10.1097/00007611-197401000-00027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|